May 3, 2024
Aqueous Film-Forming Foam, or AFFF, has been under scrutiny due to its connection to health risks associated with per- and polyfluoroalkyl substances (PFAS). According to experts, these substances can pose serious threats to human health, including an increased risk of cancer.
One study highlighted a concerning link, stating, "A study found a 56% increase in thyroid cancer risk among people exposed to higher levels of linear PFOS." This finding underscores the potential dangers of PFAS exposure in firefighting foam.
In light of these health concerns, legal action has been taken, resulting in the consolidation of lawsuits under Multi-District Litigation (MDL) overseen by Judge Richard M. Gergel. The MDL format aims to streamline the legal process for cases related to AFFF and PFAS, as noted by the statement, "About 24,000 plaintiff fact sheets have been served."
Furthermore, recent developments in the litigation include the identification of candidates for personal injury trials, indicating progress in the legal battle surrounding AFFF. Parties involved in the lawsuits are working towards addressing the complexities of the cases and seeking justice for those affected by the harmful effects of PFAS exposure.
As the legal proceedings unfold, it is crucial to monitor key dates and decisions, such as the DuPont and 3M Public Water Supplier Settlements, which mark significant milestones in the litigation process. Additionally, the identification of new injuries like liver and thyroid cancer underscores the urgency of addressing the widespread impact of AFFF on public health.
In conclusion, the ongoing litigation surrounding AFFF and its health implications serves as a stark reminder of the importance of addressing environmental and public health risks associated with firefighting foam containing toxic PFAS chemicals.